186 related articles for article (PubMed ID: 18548238)
1. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
[TBL] [Abstract][Full Text] [Related]
2. CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.
Dorado P; Berecz R; Norberto MJ; Yasar U; Dahl ML; LLerena A
Eur J Clin Pharmacol; 2003 Jul; 59(3):221-5. PubMed ID: 12734606
[TBL] [Abstract][Full Text] [Related]
3. The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.
Yasar U; Eliasson E; Forslund-Bergengren C; Tybring G; Gadd M; Sjöqvist F; Dahl ML
Eur J Clin Pharmacol; 2001 Dec; 57(10):729-35. PubMed ID: 11829203
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility over time of the urinary diclofenac/4'-OH diclofenac ratio among different CYP2C9 genotypes.
Dorado P; Berecz R; Cáceres MC; Conzález I; Llerena A
Eur J Drug Metab Pharmacokinet; 2003; 28(3):213-5. PubMed ID: 14527094
[TBL] [Abstract][Full Text] [Related]
5. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
[TBL] [Abstract][Full Text] [Related]
6. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
[TBL] [Abstract][Full Text] [Related]
7. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
López-Rodríguez R; Novalbos J; Gallego-Sandín S; Román-Martínez M; Torrado J; Gisbert JP; Abad-Santos F
Pharmacol Res; 2008 Jul; 58(1):77-84. PubMed ID: 18694831
[TBL] [Abstract][Full Text] [Related]
8. Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain.
Llerena A; Alvarez M; Dorado P; González I; Peñas-LLedó E; Pérez B; Cobaleda J; Calzadilla LR
Pharmacogenomics J; 2014 Jun; 14(3):229-34. PubMed ID: 23959274
[TBL] [Abstract][Full Text] [Related]
9. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans.
Kirchheiner J; Meineke I; Steinbach N; Meisel C; Roots I; Brockmöller J
Br J Clin Pharmacol; 2003 Jan; 55(1):51-61. PubMed ID: 12534640
[TBL] [Abstract][Full Text] [Related]
11. Effects of CYP2C9*3 and CYP2C9*13 on Diclofenac Metabolism and Inhibition-based Drug-Drug Interactions.
Zi J; Liu D; Ma P; Huang H; Zhu J; Wei D; Yang J; Chen C
Drug Metab Pharmacokinet; 2010; 25(4):343-50. PubMed ID: 20814155
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
Kudzi W; Dodoo AN; Mills JJ
BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
[TBL] [Abstract][Full Text] [Related]
13. Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways.
Bort R; Macé K; Boobis A; Gómez-Lechón MJ; Pfeifer A; Castell J
Biochem Pharmacol; 1999 Sep; 58(5):787-96. PubMed ID: 10449188
[TBL] [Abstract][Full Text] [Related]
14. Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.
Jaja C; Bowman L; Wells L; Patel N; Xu H; Lyon M; Kutlar A
Clin Transl Sci; 2015 Aug; 8(4):272-80. PubMed ID: 25640739
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
[TBL] [Abstract][Full Text] [Related]
16. [Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs].
Martínez C; Blanco G; García-Martín E; Agúndez JA
Farm Hosp; 2006; 30(4):240-8. PubMed ID: 17022718
[TBL] [Abstract][Full Text] [Related]
17. Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9*3 allele.
Shimamoto J; Ieiri I; Urae A; Kimura M; Irie S; Kubota T; Chiba K; Ishizaki T; Otsubo K; Higuchi S
Eur J Clin Pharmacol; 2000 Apr; 56(1):65-8. PubMed ID: 10853880
[TBL] [Abstract][Full Text] [Related]
18. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
19. Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios.
Dorado P; Berecz R; Cáceres MC; LLerena A
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(2):437-42. PubMed ID: 12742136
[TBL] [Abstract][Full Text] [Related]
20. Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor.
Martínez C; García-Martín E; Alonso-Navarro H; Jiménez-Jiménez FJ; Benito-León J; García-Ferrer I; Vázquez-Torres P; Puertas I; Zurdo JM; López-Alburquerque T; Agúndez JA
Neuromolecular Med; 2007; 9(2):195-204. PubMed ID: 17627038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
